See Value In Pharma Stocks: Andrew Holland

PUBLISHED ON: July 26, 2016 | Duration: 24 min, 53 sec

   
loading..
Andrew Holland, CEO of Ambit Investment Advisors, says value has emerged in pharma sector in a month or so after FDA inspections and rulings. Pharms stocks are ripe for re-rating and within that re-rating there will be a switch back to the pharma sector from IT sector, added Mr Holland.
ALSO WATCH
Money Moving From Real Estate Into Equities, Says Saurabh Mukherjea

................................ Advertisement ................................

................................ Advertisement ................................